Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | X | 12906527 | intron variant | G/C | snv |
|
0.700 | 0 | |||||||||||||
|
1.000 | X | 12906538 | intron variant | T/A | snv |
|
0.700 | 0 | |||||||||||||
|
0.752 | 0.320 | X | 12906707 | start lost | A/G | snv | 0.31 | 0.30 |
|
Infections; Respiratory Tract Diseases | 0.030 | 1.000 | 3 | 2011 | 2019 | ||||||
|
0.752 | 0.320 | X | 12906707 | start lost | A/G | snv | 0.31 | 0.30 |
|
Digestive System Diseases; Infections | 0.030 | 1.000 | 3 | 2014 | 2018 | ||||||
|
0.807 | 0.320 | X | 12906578 | intron variant | C/G | snv | 0.30 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.020 | 1.000 | 2 | 2014 | 2016 | |||||||
|
0.807 | 0.320 | X | 12906578 | intron variant | C/G | snv | 0.30 |
|
Digestive System Diseases; Infections | 0.020 | 1.000 | 2 | 2014 | 2018 | |||||||
|
0.752 | 0.320 | X | 12906707 | start lost | A/G | snv | 0.31 | 0.30 |
|
Infections | 0.020 | 1.000 | 2 | 2008 | 2018 | ||||||
|
0.752 | 0.320 | X | 12906707 | start lost | A/G | snv | 0.31 | 0.30 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.020 | 1.000 | 2 | 2014 | 2016 | ||||||
|
1.000 | 0.080 | X | 12914412 | intron variant | C/T | snv | 0.51 |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.200 | X | 12920993 | synonymous variant | G/A;C | snv | 0.54 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.882 | 0.200 | X | 12920993 | synonymous variant | G/A;C | snv | 0.54 |
|
Infections; Respiratory Tract Diseases | 0.010 | < 0.001 | 1 | 2016 | 2016 | |||||||
|
0.882 | 0.200 | X | 12920993 | synonymous variant | G/A;C | snv | 0.54 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.200 | X | 12920993 | synonymous variant | G/A;C | snv | 0.54 |
|
Infections | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
X | 12905562 | intron variant | A/G | snv | 0.29 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
0.807 | 0.320 | X | 12906578 | intron variant | C/G | snv | 0.30 |
|
Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2009 | 2009 | |||||||
|
0.807 | 0.320 | X | 12906578 | intron variant | C/G | snv | 0.30 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.807 | 0.320 | X | 12906578 | intron variant | C/G | snv | 0.30 |
|
Infections; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.807 | 0.320 | X | 12906578 | intron variant | C/G | snv | 0.30 |
|
Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.752 | 0.320 | X | 12906707 | start lost | A/G | snv | 0.31 | 0.30 |
|
Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2009 | 2009 | ||||||
|
0.752 | 0.320 | X | 12906707 | start lost | A/G | snv | 0.31 | 0.30 |
|
Infections | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.752 | 0.320 | X | 12906707 | start lost | A/G | snv | 0.31 | 0.30 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.752 | 0.320 | X | 12906707 | start lost | A/G | snv | 0.31 | 0.30 |
|
Infections | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
|
0.752 | 0.320 | X | 12906707 | start lost | A/G | snv | 0.31 | 0.30 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.752 | 0.320 | X | 12906707 | start lost | A/G | snv | 0.31 | 0.30 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.752 | 0.320 | X | 12906707 | start lost | A/G | snv | 0.31 | 0.30 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 |